A common reality: How augmented reality is transforming the future of pharmaceutical marketing
In the second installment of a three-part series exploring virtual and augmented reality, Harrison Gaiger explores the ways in which AR is transforming the future of pharmaceutical marketing.
In a previous article I explored the growing role that Virtual Reality (VR) is playing in the healthcare industry, including its use as a marketing tool for pharmaceutical companies, and questioned what the future of VR may look like in a world where technological advancements are being made every day. It seemed clear to me that while VR is still in the early stages of medical application, it’s already making a huge impact on the healthcare industry and that, regardless of its infancy, VR technology is most likely here to stay. Because of this I concluded by saying that tech-savvy pharmaceutical marketers should consider adding it to their future strategies as an invaluable means for engaging with customers. In the second instalment of this three-part series, I look at the ways in which Augmented Reality (AR) is transforming the future of pharmaceutical marketing.
Game changer? The role of virtual reality in healthcare
In the first installment of three-part series exploring virtual and augmented reality, Harrison Gaiger outlines the medical applications of VR and how pharma can leverage this innovative technology in the future.
The next decade promises to be an exciting time for science and innovation. Technological advancements are being made on a daily basis and many of these have the potential to directly impact our everyday lives. In fact, technology is changing at such a rate that it can often seem difficult to keep up. One technological advancement with the potential to change how we interact with technology and each other is Virtual Reality (VR) – immersive computer-generated environments that place users in seemingly life-like situations with which they can interact. VR, once the stuff of science-fiction, is now becoming a viable mainstream product.
Connected Patients - Adopting a patient-centric approach in emerging markets
The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going to be critical to future success.
From chaos to calm: how to make sense of social media
What do you know about chaos theory?
What do you know about chaos theory? Chaos theory was recently described to me at a rudimentary level as being about the science of surprises, of the nonlinear and the unpredictable. This got me thinking about social media and how to makes sense of what is being said online.
Did you know that on average around 6,000 tweets are posted every second? That’s 350,000 tweets a minute, 500 million tweets a day and 200 billion tweets a year – and that’s just one form of social media.
It’s fair to say that the way we communicate has been transformed by online interaction. We post, blog, tweet, “like”, “pin” and talk through online and social media mechanisms, all of which has an impact on commerce and industry today. They say “a brand is no longer what we tell the consumer it is – it is what consumers tell each other it is” (Scott Cook co-founder Intuit) and this causes problems for marketers, who for so long have been used to controlling the conversation with their consumers. Social media has changed this dynamic.
What does this mean for pharma?
Digital Services Group established
Research Partnership has formed a Digital Services Group.
Led by Director John Branston, the group will build on existing capabilities and explore the latest digital research approaches in order to develop and apply these advanced techniques within pharmaceutical market research.